Organisation paid for research Program year 2025 Source: CMS Open Payments

Juno Research

Neither a doctor nor a teaching hospital

Research payments

$923,668

474 payments

Through program year 2025, Juno Research is reported as receiving $923,668 in research payments, across 474 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2025	Research	$269,391	10
2024	Research	$81,955	3
2020	Research	$199,320	195
2019	Research	$373,002	266

Breakdown

Who paid Research payments · program years 2019–2025

AstraZeneca Pharmaceuticals LP $469,869 15 payments
Novo Nordisk AS $401,797 446 payments
Ionis Pharmaceuticals, Inc. $32,187 7 payments
AstraZeneca UK Limited $19,436 2 payments
Pfizer Inc. $380 4 payments

Studies the money was for Research payments · program years 2019–2025

Nn9535-4506 $262,770 297 payments
A Phase II Randomised Double blind Placebo controlled Study to Evaluate the Efficacy Safety and Tolerability of AZD5004 in Participants living with Obesity or Overweight with Comorbidity $218,228 1 payment
A Phase IIb Randomised Parallel Double Blind Placebo Controlled and Open Label Active Comparator Study to Evaluate the Efficacy and Safety of MEDI0382 in the Treatment of Overweight and Obese Subjects with Type 2 Diabetes Mellitus $86,468 3 payments
A Randomised,Double Blind,Placebo Controlled,Parallel Group Study to Assess the Efficacy and Safety of Baxdrostat in Participants with Uncontrolled Hypertension on Two or More Medications including Participants with Resistant Hypertension $82,503 3 payments
A Long Term Outcomes Study to Assess STatin Residual Risk Reduction with EpaNova in HiGh Cardiovascular Risk PatienTs with Hypertriglyceridemia $62,933 6 payments
Nn9535-4321 $47,987 134 payments
Nn1250-4252 $43,838 5 payments
Is354cs9 $32,187 7 payments
Nn9535-4270 $22,918 2 payments
A Multinational Randomised Double Blind Placebo Controlled Trial to Evaluate the Effect of Ticagrelor 90 mg twice daily on the Incidence of Cardiovascular Death Myocardial Infarction or Stroke in Patients with Type 2 Diabetes $20,743 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.